Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Oric PharmaceuticalsORIC | Open-market sale10b5-1 plan | 09/28 | 09/29 | 13,400 sh | $13.53 | $181,257.78 | −16.1% | |
CFO | Oric PharmaceuticalsORIC | Open-market sale10b5-1 plan | 09/24 | 09/25 | 600 sh2 trades | $13.50avg. | $8,102.5 | −0.9% |
Oric PharmaceuticalsORIC | Open-market sale10b5-1 plan | 02/24 | 02/26 | 52,000 sh | $13.51 | $702,520 | −43.3% | |
Oric PharmaceuticalsORIC | Open-market sale10b5-1 plan | 01/16 | 01/20 | 6,700 sh2 trades | $12.00avg. | $80,400 | No record | |
Pratik S. MultaniChief Medical Officer | Oric PharmaceuticalsORIC | Open-market sale | 25/12/16 | 25/12/17 | 10,720 sh | $9.06 | $97,123.2 | −13.6% |
Jacob ChackoPresident and CEO | Oric PharmaceuticalsORIC | Open-market sale | 25/12/16 | 25/12/17 | 33,374 sh | $9.06 | $302,368.44 | −5.4% |
Oric PharmaceuticalsORIC | Open-market sale | 25/12/16 | 25/12/17 | 10,720 sh | $9.06 | $97,123.2 | −13.6% | |
Jacob ChackoPresident and CEO | Oric PharmaceuticalsORIC | Open-market sale10b5-1 plan | 25/10/06 | 25/10/08 | 37,461 sh | $12.32 | $461,519.52 | −6.6% |
Oric PharmaceuticalsORIC | Open-market sale10b5-1 plan | 25/10/06 | 25/10/08 | 11,000 sh | $14.52 | $159,720 | −18.5% | |
Oric PharmaceuticalsORIC | Open-market sale10b5-1 plan | 25/09/30–25/10/01 | 25/10/02 | 87,539 sh2 trades | $12.03avg. | $1,053,463.43 | −13.3% | |
Jacob ChackoPresident and CEO | Oric PharmaceuticalsORIC | Open-market sale10b5-1 plan | 25/09/22 | 25/09/24 | 125,000 sh | $10.80 | $1,350,000 | −16.0% |
Oric PharmaceuticalsORIC | Open-market sale10b5-1 plan | 25/07/01 | 25/07/02 | 20,000 sh | $10.05 | $201,000 | −29.3% | |
CFO | Oric PharmaceuticalsORIC | Open-market sale10b5-1 plan | 25/06/23–25/06/24 | 25/06/24 | 33,500 sh3 trades | $10.48avg. | $351,237.5 | −32.9% |
Oric PharmaceuticalsORIC | Open-market buy | 25/06/20–25/06/23 | 25/06/23 | 28,000 sh2 trades | $9.39avg. | $262,976.12 | No record | |
Oric PharmaceuticalsORIC | Open-market sale10b5-1 plan | 25/06/12 | 25/06/13 | 300 sh | $10.00 | $3,000 | −0.3% | |
CFO | Oric PharmaceuticalsORIC | Open-market sale10b5-1 plan | 25/06/10–25/06/11 | 25/06/11 | 3,300 sh3 trades | $10.01avg. | $33,017 | −3.1% |
CFO | Oric PharmaceuticalsORIC | Open-market sale10b5-1 plan | 25/06/06–25/06/09 | 25/06/09 | 2,900 sh2 trades | $10.01avg. | $29,026 | −2.7% |
Pratik S. MultaniChief Medical Officer | Oric PharmaceuticalsORIC | Open-market sale | 24/12/16 | 24/12/17 | 8,850 sh | $8.28 | $73,278 | −15.9% |
Jacob ChackoPresident and CEO | Oric PharmaceuticalsORIC | Open-market sale | 24/12/16 | 24/12/17 | 24,660 sh | $8.28 | $204,184.8 | −3.1% |
Oric PharmaceuticalsORIC | Open-market sale | 24/12/16 | 24/12/17 | 8,851 sh | $8.28 | $73,286.28 | −7.7% |
